Agent Capital, LLCFirm match from fund name (lower confidence)
Agent Capital Fund III LP
Open: first sale Feb 2024, per Form D (fund age approximates vintage)
- Vintage
- 2024
- Fund size
- $53.25M to $100M (Form D)
- Stages
- Seed, Series A, Growth
- Sectors
- Biotech
- Regions
- Not stated
01 · Thesis
Agent Capital is a healthcare venture capital firm that makes direct equity investments in novel, differentiated therapeutics that address unmet patient needs. It invests across all stages, from preclinical to commercial, with a focus on rare diseases, oncology, neurology and immunology.Inferred from the firm's website
02 · Initial check
$533K to $1.67M (estimated from fund size)
Estimated from Form D: $53.25M sold of a $100M target
03 · Who to approach
Named on this fund's Form D
- Geeta Vemuri, Managing Member of the General Partner and Managing Partner of the Management Company
04 · Deals
No deals attributed to this fund yet.
05 · Evidence
Firm-wideAgent Capital is a healthcare venture capital firm focused on investing in novel, differentiated therapeutics and treatments that address unmet patient needs.
Agent Capital is a healthcare venture capital firm focused on investing in novel, differentiated therapeutics and treatments that address unmet patient needs.
https://www.agentcapital.com/about/
06 · Sources
Last verified: Oct 28, 2026